California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Allergan, Teva to pay $54M in San Francisco opioid lawsuit
Teva CEO says company could pay up to $3.6B to put opioid litigation to bed: report | Fierce Pharma
Opioid Lawsuit Against Teva Pharma
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
Texas settles another opioid lawsuit, wins $225 million against Teva
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva drops lawsuit with Amicus over Creates Act dispute
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business Journal
Drug Companies Teva, Allergan Ready to Pay $5 Billion to Resolve Opioid Suits - Bloomberg
Teva & Allergan Settle WV Opioid Lawsuit For Over $160 Million | MedTruth - Prescription Drug & Medical Device Safety | Informed Advocacy
New York Jury Finds Drugmaker Teva Liable for Fueling Opioid Crisis
Teva to Pay $420M to Settle Shareholders' Generic Drug Pricing Lawsuit — Report - TipRanks.com
Teva Pharmaceuticals will pay $420 million in a federal case
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva agrees to $4.35B settlement to end opioid lawsuits - Top Class Actions
